Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Drug:
monoclonal antibody A33
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I/II Study of 131I-Labeled Monoclonal Antibody A33 in Patients with Advanced Colorectal Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
20 and over
Sponsor:
Protocol IDs:
MSKCC-90143
, NCI-V91-0004
2.
Phase II Study of Humanized Monoclonal Antibody A33 in Advanced Colorectal Carcinoma (Summary Last Modified 06/98)
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
MSKCC-96022
, NCI-V96-0917
3.
Phase I Study of 5-FU and 131I-Labeled MOAB A33 Radioimmunotherapy in Patients with Advanced Colon Carcinoma (Summary Last Modified 08/94)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Protocol IDs:
MSKCC-93151
, NCI-V94-0406
4.
Phase I Study of Humanized Monoclonal Antibody A33 in Advanced Colorectal Carcinoma (Summary Last Modified 07/95)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
over 18
Sponsor:
NCI
Protocol IDs:
MSKCC-94100
, NCI-H95-0616
5.
Phase I Study of Humanized Monoclonal Antibody A33 Plus Carmustine, Fluorouracil, Vincristine, and Streptozocin in Patients with Advanced Colorectal Cancer (Summary Last Modified 06/2000)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSKCC-98056
, NCI-H98-0022, NCT00003543
6.
Phase I Study of 125I-MOAB A33 in Patients with Advanced Colorectal Carcinoma
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
Over 16
Sponsor:
Protocol IDs:
MSKCC-92131
, NCI-V93-0213
7.
Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
LUD2003-005
, NCT00199797
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute